The Cannabis Stock Big Money Managers Are Quietly Buying
These include Susquehanna International Group, which increased its position by around 2.75 million shares during Q3 2025. Other quantitative traders, including Citadel, Millennium Management, and D.E.
Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro’s 2026 Product Catalog
Figure 1. Cannabix Technologies Inc. Marijuana Breath Test featured on cover of 2026 AlcoPro, Inc. product catalog Cannabix and AlcoPro have been working closely together on pre-launch marketing …
Want to buy some of the best marijuana stocks for 2026? Consider this ETF.
The cannabis sector is one that most investors would probably describe as a former bubble. But today, with valuations coming down significantly across the board and recent news that President Trump …
Trump’s ‘common sense’ overhaul of marijuana rules could boost budding industry. But investors should be on high alert
“The facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” Trump continued to reporters. “In some cases, this …
What a quick boom-bust in pot stocks told us about policy risk in 2026
Investors are still making rash, knee-jerk decisions off of little more than a hope and a prayer,” says Portfolio Manager …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
What a quick boom-bust in pot stocks told us about policy risk in 2026
Investors are still making rash, knee-jerk decisions off of little more than a hope and a prayer,” says Portfolio Manager …
Riding the marijuana reclassification wave: 3 stocks to watch in 2026
After years of muted growth and battered stock prices, the sector finally began showing signs of life as long-awaited regulatory progress moved closer to reality. Earlier this month, President Trump …
What cannabis investors should watch for in 2026 after marijuana rescheduling
Cannabis investors may be feeling bullish entering 2026 after marijuana rescheduling, but some more advances are needed for growth.
President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?
Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.
Cannabis use is up 46% among American seniors as Trump signs an order to reclassify marijuana. Are you positioned to profit if pot stocks surge?
This comes at a time when cannabis use among boomers is, well, booming. The number of Americans aged 65+ using cannabis for medical purposes rose from 4.8% in 2021 to 7% in 2023, a 46% jump in just …
Trump reschedules cannabis, leaving opening for hemp industry
On Thursday, President Trump signed an executive order, Increasing Medical Marijuana and Cannabidiol Research, that moves cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA …
President Donald Trump just fast-tracked the rescheduling of marijuana, and pot stocks plunged — here’s the nefarious reason why
Pot stocks Trulieve Cannabis, Curaleaf, Cresco Labs, Green Thumb Industries, and Canopy Growth plummeted by up to 39% due to the scope of Trump’s intentions. However, there’s a silver lining for …
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
The best cannabis stocks to follow Trump’s Schedule III classification are high-quality names with access to the Canadian market. Click here to see the top stocks.
Trump’s marijuana order isn’t helping cannabis stocks
Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug. The Department …
Recent Comments